← Leaderboards
James R Van Brocklyn
Ohio State University
$1,492,171
Attributed
$1,492,171
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $280.3K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,492,171 · 2
By mechanism
R01$1,120,921 · 1
R21$371,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Deliang Guo$11,121,635
- Deepa Sampath$2,215,864
- Michael A Caligiuri$65,062,344
- Paul Stoodley$4,461,832
- Balveen Kaur$17,543,202
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaG ProteinTissue /Cell CultureNeoplastic ProcessReceptorHuman TissueReceptor CouplingPolymerase Chain ReactionSphingolipidsReceptor ExpressionIn Situ HybridizationGene MutationMolecular OncologyClinical ResearchLaser Capture MicrodissectionCell ProliferationCell MotilityBrain NeoplasmsCell LineCell GrowthBrainAngiogenesisEpidermal Growth FactorEnzymes
Grant awards (6)
The Role of Sphingosine Kinase in Glioblastoma Stem Cells$168,750
R21 · FY2009 · CA · contact PI
The Role of Sphingosine Kinase in Glioblastoma Stem Cells$202,500
R21 · FY2008 · CA · contact PI
Role of Multiple EDG Receptors in Glioma Cell Growth$280,250
R01 · FY2005 · NS
Role of Multiple EDG Receptors in Glioma Cell Growth$280,250
R01 · FY2004 · NS
Role of Multiple EDG Receptors in Glioma Cell Growth$280,250
R01 · FY2003 · NS
Role of Multiple EDG Receptors in Glioma Cell Growth$280,171
R01 · FY2002 · NS